share_log

UBS Adjusts Shenzhen Kangtai Biological Products’ Price Target to 66 Yuan From 72.50 Yuan, Keeps at Buy

UBS Adjusts Shenzhen Kangtai Biological Products’ Price Target to 66 Yuan From 72.50 Yuan, Keeps at Buy

瑞銀將深圳康泰生物製品的目標價從72.50元上調至66元,保持買入狀態
MT Newswires ·  2022/08/22 05:16

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論